Quantcast
Last updated on April 23, 2014 at 21:24 EDT

Latest Sunitinib Stories

2008-08-25 09:00:26

Leading UK cancer experts have accused a health watchdog of forcing patients to remortgage their homes to afford treatments freely available in Europe. The group of 26 professors were "dismayed" at guidance issued by the National Institute for Health and Clinical Excellence (Nice) to deny patients four vital kidney cancer drugs on the NHS. They said the decision showed it was time for a "radical change" in how the NHS makes decisions on what treatments are available for cancer sufferers....

2008-08-25 09:00:26

By Nicola Fenwick CANCER experts have accused a health watchdog of forcing patients to remortgage their homes to pay for treatments freely available in Europe. The group of 26 professors are dismayed at guidance issued by the National Institute for Health and Clinical Excellence (Nice) that deny four kidney cancer drugs on the NHS. Earlier this month, Nice said the drugs + Sutent (sunitinib), Avastin (bevacizumab), Nexavar (sorafenib) and Torisel (temsirolimus) ? were not...

2008-08-20 09:00:22

The National Institute for Health and Clinical Excellence, UK has rejected four kidney cancer treatments for use on the National Health Service on grounds that the drugs are not cost effective, according to PharmaTimes. The draft guidance issued by the National Institute for Health and Clinical Excellence (NICE), contends that Roche's Avastin (bevacizumab), Bayer's Nexavar (sorafenib), Pfizer's Sutent (sunitinib) and Wyeth's Torisel (temsirolimus) are costly for the treatment of advanced or...

2008-08-18 09:01:01

By Gavin Engelbrecht THE Government?s drugs approval agency warned last night it might not be able to meet a pledge to speed up decision-making on new treatments. Campaigners and patients have criticised Nice ? the National Institute for Health and Clinical Excellence ? over the time it takes to approve lifegiving drugs. Health Secretary Alan Johnson has pledged to bring decision- making on new drugs down from an average length of two years to only three months. But Andrew Dillon, the...

2008-08-17 18:00:52

Regarding the drug Sutent which was refused to Mrs Hopkins who dedicated 42 years of her life to the health service, all I can ask is how can we afford to give benefits to some of these immigrants who have never put a single penny into our communities? It seems to me the less you work, the more help you seem to get. J GRIFFITHS Hanley (c) 2008 Sentinel, The (Stoke-on-Trent UK). Provided by ProQuest LLC. All rights Reserved.

2008-08-17 18:00:12

A Leading Welsh cancer specialist has condemned plans to prevent patients with advanced kidney cancer from getting specialised drug treatments. The National Institute for Health and Clinical Excellence (Nice) has issued draft guidance rejecting the use of Sutent, Avastin, Nexavar and Torisel on cost grounds, leaving only interferon available to clinicians. John Wagstaff, honorary consultant in medical oncology at the South Wales Cancer Institute in Swansea and director of the Wales Cancer...

2008-08-11 09:01:39

By David Roberts A SURVEY has revealed more than 1,300 cancer patients nationwide are being denied vital drugs because of a ?postcode lottery? over who gets access to them. The Rarer Cancers Forum has found that in some areas of the country 100 per cent of patients were granted access to the medicine, whereas in others not a single person received the treatment. The information has been obtained under the Freedom of Information Act from 62 of England?s 152 primary care trusts (PCTs)....

2008-08-11 03:00:47

COVENTRY health chiefs are supporting a draft decision to reject four new cancer drugs for patients with advanced kidney cancer. The National Institute for Health and Clinical Excellence (Nice) decided that sunitinib, bevacizumab, sorafenib and Torisel are not a cost-effective use of NHS cash. For example bevacizumab costs around pounds 23,000 per patient per year. Dr Peter Barker, public health consultant at Coventry Teaching Primary Care Trust (PCT) said: "Coventry PCT is supportive...

2008-08-09 06:00:22

By Barry Nelson A CANCER patient who has survived in the past year because of a wonder drug has condemned plans to deny it to other patients because of the cost. Stan Craddock, 63, from Darlington, said he survived the past ten months because of the drug Sutent. Last night, he said he could not believe that such a powerful cancer drug was effectively going to be banned by the NHS. This followed the draft guidance from the National Institute for Health and Clinical Excellence (Nice)...

2008-08-09 03:00:08

TWO cancer sufferers from Warwickshire have been left angered by a national medical board's decision not to fund a life-lengthening wonder drug. As featured in the Telegraph, Ade Cure, from Wellesbourne, and Colin Howe, from Rugby, are both dying of kidney cancer. But PCTs in Warwickshire and Coventry won't routinely prescribe the life-prolonging drug Sutent to sufferers of kidney and gastrointestinal cancer. Their decision was backed on Thursday by the National Institute for Health and...